You may also like
Evaluation of Point-of-Care ACT Coagulometers and Anti-Xa Activity During Cardiopulmonary Bypass
This suggests that ACT devices should not be used interchangeably, but cut-off values for safe anticoagulation during cardiopulmonary bypass should be determined for each type of device, particularly when switching supplier.
1 min read
Experimental Studies on Artificial Blood Usage for Hemodilution during Cardiopulmonary Bypass
The purpose of this study was to evaluate a novel perfluoro-octyl bromide (PFOB) emulsion, one of perfluorochemicals (PFCs) emulsions, administered during hemodilution CPB.
1 min read
Perfusion Community Sustains Great Loss in the Death of Viktor Magnusson
The perfusion community has sustained a great loss. Viktor Magnusson, Chief Perfusionist in Reykjavik, Iceland, died Wednesday August, 30th . Viktor’s background […]
1 min read